Last progress January 23, 2025 (10 months ago)
Introduced on January 23, 2025 by Robert E. Latta
Referred to the House Committee on Energy and Commerce.
This bill would block the FDA from approving any new drugs used to end a pregnancy and would stop or block new research exemptions for those drugs. It also adds stricter rules for drugs that are already approved, like making them prescription-only and limiting their use to the first 70 days of pregnancy .
For drugs already on the market, the bill requires in-person dosing by the prescriber at a clinic, doctor’s office, or hospital—not at a pharmacy or by mail. Prescribers must have special certification and be able to confirm how far along the pregnancy is, check for ectopic pregnancy, and provide or arrange emergency care, including surgery and blood transfusions, if needed. It also requires broad reporting of complications by prescribers, manufacturers, and other health workers, and says states and the federal government may add more restrictions. Ongoing research exemptions would be canceled three years after the law takes effect if they would violate these new limits .
Key points